{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Waitzfelder B"],"funding":["National Center for Advancing Translational Sciences, National Institutes of Health, Award Number","National Heart, Lung, and Blood Institute, National Institutes of Health"],"pagination":["885"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10184427"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["23(1)"],"pubmed_abstract":["<h4>Background</h4>Cardiovascular disease (CVD) remains the leading cause of death in the US. CVD incidence is influenced by many demographic, clinical, cultural, and psychosocial factors, including race and ethnicity. Despite recent research, there remain limitations on understanding CVD health among Asians and Pacific Islanders (APIs), particularly some subgroups and multi-racial populations. Combining diverse API populations into one study group and difficulties in defining API subpopulations and multi-race individuals have hampered efforts to identify and address health disparities in these growing populations.<h4>Methods</h4>The study cohort was comprised of all adult patients at Kaiser Permanente Hawai'i and Palo Alto Medical Foundation in California during 2014-2018 (n = 684,363). E"],"journal":["BMC public health"],"pubmed_title":["Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California."],"pmcid":["PMC10184427"],"funding_grant_id":["HL 126172","1UL1TR003142"],"pubmed_authors":["Rawlings AM","Chung S","Daida YG","Li J","Varga A","Frankland TB","Kaholokula JK","Waitzfelder B","Howick C","Palaniappan L","Bacong AM","Fortmann SP"],"additional_accession":[]},"is_claimable":false,"name":"Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California.","description":"<h4>Background</h4>Cardiovascular disease (CVD) remains the leading cause of death in the US. CVD incidence is influenced by many demographic, clinical, cultural, and psychosocial factors, including race and ethnicity. Despite recent research, there remain limitations on understanding CVD health among Asians and Pacific Islanders (APIs), particularly some subgroups and multi-racial populations. Combining diverse API populations into one study group and difficulties in defining API subpopulations and multi-race individuals have hampered efforts to identify and address health disparities in these growing populations.<h4>Methods</h4>The study cohort was comprised of all adult patients at Kaiser Permanente Hawai'i and Palo Alto Medical Foundation in California during 2014-2018 (n = 684,363). E","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 May","modification":"2025-04-22T14:46:17.132Z","creation":"2025-04-06T01:06:37.64Z"},"accession":"S-EPMC10184427","cross_references":{"pubmed":["37189145"],"doi":["10.1186/s12889-023-15795-5"]}}